ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
Author(s) -
Carl Koschmann,
AndaAlexandra Calinescu,
Felipe J. Núñez,
Alan Mackay,
Janet Fazal-Salom,
Danièl Thomas,
Flor Mendez,
Neha Kamran,
Marta Dzaman,
Lakshman Mulpuri,
Johnathon Krasinkiewicz,
Robert Doherty,
Rosemary Lemons,
Jacqueline A. BrosnanCashman,
Youping Li,
Soyeon Roh,
Lili Zhao,
Henry D. Appelman,
David O. Ferguson,
Vera Gorbunova,
Alan K. Meeker,
Chris Jones,
Pedro R. Löwenstein,
María G. Castro
Publication year - 2016
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aac8228
Subject(s) - atrx , non homologous end joining , glioma , dna repair , dna damage , dna , cancer research , biology , microbiology and biotechnology , medicine , genetics , mutation , gene
The loss of ATRX impairs DNA repair, promoting glioma growth but enhancing sensitivity to DNA-damaging therapies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom